Sectors
CTOR
Citius Oncology, Inc.
0.76
2 x 0.55
2 x 1.00
bid
ask
-
0.01
1.60%
2 @ 07:02 AM
0.76 -0.00 (0.41%)
| Ytd | -23.68% | |
| 1y | -64.83% |
0.75
day range
0.82
0.49
52 week range
2.25
| Open | 0.82 | Prev Close | 0.78 | Low | 0.75 | High | 0.82 | Mkt Cap | 80.72M |
| Vol | 38.24K | Avg Vol | 82.07K | EPS | -0.48 | P/E | N/A | Forward P/E | N/A |
| Beta | 3.48 | Short Ratio | 0.37 | Inst. Own | 0.70% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 0.69 | 200-d Avg | 0.91 | 1yr Est | 3.00 |
CTOR News
benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers INVO Fertility (NASDAQ:IVF) shares increased by 163.4% to $2.56 during Monday's pre-mar
benzinga.com
Why HIVE Digital Technologies Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premar
HIVE Digital Technologies Ltd (NASDAQ: HIVE) rose in pre-market trading due to its subsidiary's
benzinga.com
Citius Oncology Q3 EPS $(0.08), Inline, Sales $1.494M Miss $2.500M Estimate
Citius Oncology (NASDAQ:CTOR) reported quarterly losses of $(0.08) per share which met the analyst c
benzinga.com
Citius Oncology Reports 78% QoQ Growth In New Institutional Accounts Ordering LYMPHIR; Near‑Universa
New institutional accounts ordering LYMPHIR increased 78% quarter over quarterLYMPHIR's near-uni